Contraception for women with congenital heart disease

Marla A Mendelson*

*Corresponding author for this work

Research output: Contribution to journalShort survey

5 Citations (Scopus)

Abstract

Barrier methods of birth control are less efficacious than other methods but pose significantly less risk of systemic complications for women with congenital heart disease. These methods require a motivated patient and a cooperative partner. Male contraception was not discussed in this article but certainly should be considered when counseling a couple. At present, essentially the only permanent option for male contraception is a vasectomy, but other methods are under investigation. Sterilization is not recommended uniformly in women with cardiovascular disease when pregnancy is feasible and not contraindicated. It may be considered an option for women with contraindications to pregnancy, but these patients may also be at increased risk from the sterilization procedure.

Original languageEnglish (US)
Pages (from-to)266-269
Number of pages4
JournalHeart Disease and Stroke
Volume3
Issue number5
StatePublished - Jan 1 1994

Fingerprint

Contraception
Heart Diseases
Vasectomy
Pregnancy
Counseling
Cardiovascular Diseases

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Neuropsychology and Physiological Psychology

Cite this

@article{3d247a7a78ae4e65a593f9c493779920,
title = "Contraception for women with congenital heart disease",
abstract = "Barrier methods of birth control are less efficacious than other methods but pose significantly less risk of systemic complications for women with congenital heart disease. These methods require a motivated patient and a cooperative partner. Male contraception was not discussed in this article but certainly should be considered when counseling a couple. At present, essentially the only permanent option for male contraception is a vasectomy, but other methods are under investigation. Sterilization is not recommended uniformly in women with cardiovascular disease when pregnancy is feasible and not contraindicated. It may be considered an option for women with contraindications to pregnancy, but these patients may also be at increased risk from the sterilization procedure.",
author = "Mendelson, {Marla A}",
year = "1994",
month = "1",
day = "1",
language = "English (US)",
volume = "3",
pages = "266--269",
journal = "Heart Disease and Stroke",
issn = "1058-2819",
number = "5",

}

Contraception for women with congenital heart disease. / Mendelson, Marla A.

In: Heart Disease and Stroke, Vol. 3, No. 5, 01.01.1994, p. 266-269.

Research output: Contribution to journalShort survey

TY - JOUR

T1 - Contraception for women with congenital heart disease

AU - Mendelson, Marla A

PY - 1994/1/1

Y1 - 1994/1/1

N2 - Barrier methods of birth control are less efficacious than other methods but pose significantly less risk of systemic complications for women with congenital heart disease. These methods require a motivated patient and a cooperative partner. Male contraception was not discussed in this article but certainly should be considered when counseling a couple. At present, essentially the only permanent option for male contraception is a vasectomy, but other methods are under investigation. Sterilization is not recommended uniformly in women with cardiovascular disease when pregnancy is feasible and not contraindicated. It may be considered an option for women with contraindications to pregnancy, but these patients may also be at increased risk from the sterilization procedure.

AB - Barrier methods of birth control are less efficacious than other methods but pose significantly less risk of systemic complications for women with congenital heart disease. These methods require a motivated patient and a cooperative partner. Male contraception was not discussed in this article but certainly should be considered when counseling a couple. At present, essentially the only permanent option for male contraception is a vasectomy, but other methods are under investigation. Sterilization is not recommended uniformly in women with cardiovascular disease when pregnancy is feasible and not contraindicated. It may be considered an option for women with contraindications to pregnancy, but these patients may also be at increased risk from the sterilization procedure.

UR - http://www.scopus.com/inward/record.url?scp=0028006956&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028006956&partnerID=8YFLogxK

M3 - Short survey

C2 - 7820343

AN - SCOPUS:0028006956

VL - 3

SP - 266

EP - 269

JO - Heart Disease and Stroke

JF - Heart Disease and Stroke

SN - 1058-2819

IS - 5

ER -